| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615904 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 18 Pages |
Abstract
Higher FLC burden was associated with poor kidney function but not with low B12. Low B12 was seen more commonly in patients with preserved kidney function. Mean corpuscular volume was statistically but not clinically different between patients with low and normal B12 and, therefore, may not be a reliable indicator of B12 deficiency in PCDs. Prospective studies should compare B12 metabolites with FLC levels. Detection of B12 deficiency among patients with PCDs remains important to reduce neurologic dysfunction and cytopenias, sequelae common to B12 deficiency and PCDs.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Caitlyn Braschi, John Doucette, Ajai Chari,